BioLineRx Ltd.
BLRX
$3.37
-$0.10-2.88%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 477.00K | 194.00K | 427.00K | 304.00K | 255.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 477.00K | 194.00K | 427.00K | 304.00K | 255.00K |
| Cost of Revenue | 95.00K | 40.00K | 84.00K | 72.00K | 34.00K |
| Gross Profit | 382.00K | 154.00K | 343.00K | 232.00K | 221.00K |
| SG&A Expenses | 858.00K | 1.12M | 831.00K | 209.00K | 989.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.48M | 3.58M | 2.63M | 2.61M | 2.65M |
| Operating Income | -3.00M | -3.39M | -2.21M | -2.30M | -2.39M |
| Income Before Tax | -2.59M | -2.24M | -977.00K | -3.94M | 5.13M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.59M | -2.24M | -977.00K | -3.94M | 5.13M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 987.00K | 851.00K | -- | -- | -- |
| Net Income | -1.60M | -1.39M | -977.00K | -3.94M | 5.13M |
| EBIT | -3.00M | -3.39M | -2.21M | -2.30M | -2.39M |
| EBITDA | -2.92M | -3.33M | -2.09M | -2.13M | -2.23M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 2.66B | 2.66B | 2.61B | 2.37B | 2.22B |
| Average Diluted Shares Outstanding | 2.66B | 2.66B | 2.61B | 2.37B | 2.22B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |